U.S. Gas Utilities Stock News

Hut 8 Corp. recently announced it had commercialized the second phase of its Beacon Point AI data center campus in Texas via a second 15-year triple-net lease for 352 MW of IT capacity with the same high-investment-grade tenant, fully contracting the site’s 1,000 MW utility allocation. This expansion lifts Beacon Point’s total base-term contract value to US$19.60 billion and positions Hut 8’s AI data center portfolio at 949 MW of contracted capacity backed entirely by investment-grade...

Universal Display stock has fallen a long way, with the share price down about 59.5% over the past five years, yet some valuation checks now flag it as potentially inexpensive relative to its fundamentals. After the company recently signalled that this year’s revenue is likely to come in at the lower end of its earlier range, investors are weighing that weaker outlook against a stock that already carries a long multi year decline. The roughly 59.5% decline over five years suggests many...

Global inflation questions, higher long term yields and energy price shocks are pushing investors to think harder about what really drives long run growth. One theme cutting across AI data centers, electric vehicles and power grids is copper supply. The Top Copper Stocks screener focuses on producers with stronger balance sheets and lower production costs, which can matter when prices move around. This article highlights three of the top stocks from that screener and explains how they fit...

Campbell's (CPB) stock has been drawing attention after a prolonged slide, with the share price down about 21% year to date and about 28% over the past year. Investors are reassessing expectations. See our latest analysis for Campbell's. At the latest share price of $21.98, Campbell's has seen short term momentum soften, with a 30 day share price return down 6.35% and a 1 year total shareholder return down 27.7%, which adds to a weaker 3 and 5 year total shareholder return record. Recent...

Solventum (NYSE:SOLV) appointed Neil Zieselman as Senior Vice President, Controller and Chief Accounting Officer. Zieselman brings finance leadership experience from prior roles at Surgery Partners Inc. and Stryker Corporation. The appointment places him in a key role overseeing Solventum's accounting and financial reporting functions. Solventum operates in the healthcare sector, where accounting rigor and clear financial reporting are closely watched by investors and regulators. A new...

Equifax stock has fallen about 29% over the past five years, yet the latest Discounted Cash Flow (DCF) estimate suggests the intrinsic value could sit well above where the market is pricing the shares today, while earnings-based multiples look closer to fair. Over five years the share price is down about 29%, which means long-term holders have seen material capital pressure even before considering today’s valuation checks. Recent revenue growth, the planned acquisition in Mexico and expanded...

Firefly Aerospace stock has had a weak month, with the share price under pressure while the market based valuation checks suggest it is not a clear bargain at current levels. The share price is down 28.3% over the past month, which puts recent performance firmly on the back foot for anyone who bought in recently. Future revenue and cash flow expectations can support the current price if they materialise, but any setbacks to execution or funding plans may weigh heavily on how investors value...

Cencora stock has delivered strong long term returns over the past five years, yet the current share price still screens as cheap relative to its intrinsic value estimate and traditional valuation multiples. With both the Discounted Cash Flow (DCF) model and the market based checks pointing in the same direction, investors are weighing how much of Cencora's story is already reflected in the price. Cencora has returned 171.7% over the past five years, which puts the recent valuation signals...

Lithia Motors, Inc. reported past second-quarter 2026 results showing revenue of US$9,791.3 million and net income of US$260 million, alongside updates on its dividend and share repurchases. An interesting takeaway is that while six-month net income fell to US$360.4 million, diluted EPS for the second quarter still increased, supported by significant share buybacks. Next, we’ll examine how Lithia’s higher quarterly EPS, combined with continued share repurchases, may shape its existing...

Amneal Pharmaceuticals stock has delivered a very strong 345.7% return over the past 3 years, yet its valuation checks lean more on the expensive side rather than flagging it as a clear bargain. Over the last 3 years Amneal Pharmaceuticals has returned 345.7%, which puts extra focus on whether the current share price already reflects much of the good news. Recent earnings strength and higher expectations for future revenue and profit can support the current valuation, but any disappointment...

In late July 2026, Everforth, Inc. reported second-quarter 2026 results showing sales of US$1,007.0 million and net income of US$14.2 million, issued third-quarter guidance for revenues of US$994.0 million to US$1,024.0 million and net income of US$14.5 million to US$23.0 million, and confirmed diluted EPS guidance of US$0.36 to US$0.56. Alongside softer earnings, Everforth completed a US$77.5 million buyback of 1,796,224 shares, highlighting management’s continued focus on returning capital...

Global markets are being pulled in different directions by inflation questions, shifting rate expectations and uneven growth across regions. In this kind of backdrop, many investors are looking past quarterly headlines and focusing on founders who are deeply invested in the long term. The Top Founder-Led Companies screener targets leaders with significant skin in the game and tight capital discipline. That combination can help align your interests with theirs, regardless of which sector is in...

In late July 2026, Dolby Laboratories reported third‑quarter results showing revenue of US$305 million and net income of US$28.6 million, alongside new fourth‑quarter and full‑year 2026 guidance, a US$0.36 dividend, and an expanded share repurchase authorization to US$3.65 billion. Although quarterly profit eased year on year, Dolby’s decision to raise its buyback capacity and maintain dividends underscores management’s emphasis on returning cash to shareholders while its licensing programs...

In July 2026, Wyndham Hotels & Resorts reported second-quarter revenue of US$375 million, down from US$397 million a year earlier, while net income increased to US$102 million and diluted earnings per share from continuing operations rose to US$1.36 from US$1.13. Alongside higher earnings, the company raised its full-year 2026 net revenue and global RevPAR outlook and continued its multi-year share repurchase program, signaling confidence in its business model and cash generation. Now we’ll...

In July 2026, Xerox Holdings Corporation reported second-quarter results showing revenue of US$1,922 million and net income of US$13 million, alongside a smaller six-month net loss and higher year-to-date revenue versus the prior year. The company also raised its full-year 2026 guidance to approximately US$7.60 billion in revenue and increased synergy targets from its Lexmark collaboration, highlighting progress on priorities to stabilize revenue, improve profitability, and reduce...

Peabody Energy (BTU) has drawn fresh attention after second quarter results on July 29 showed higher sales and a shift to a net loss, along with a dividend affirmation and an update on its ongoing share repurchase program. See our latest analysis for Peabody Energy. The earnings release appears to have cooled short term sentiment around Peabody Energy, with the share price down 6.5% over the past week and 30.5% year to date, although the 1 year total shareholder return of 34.3% and 5 year...

BD (Becton, Dickinson and Company) and EMS previously announced a collaboration to launch a semaglutide therapy in Brazil, using BD’s Vystra Injection Pen platform designed for ease of use in treating chronic conditions such as obesity and type 2 diabetes. This partnership highlights how BD’s drug delivery expertise is being applied to support rising demand for injectable GLP-1 therapies in a major emerging healthcare market. Next, we’ll examine how BD’s role in semaglutide delivery through...

In late July 2026, the European Commission approved Incyte’s Opzelura (ruxolitinib) cream for adults with moderate atopic dermatitis whose disease is inadequately controlled by, or unsuitable for, topical corticosteroids and calcineurin inhibitors, following supportive Phase 3b TRuE-AD4 data showing significant symptom improvement and a favorable 24-week safety profile. This second European indication for Opzelura, alongside its existing approval in non-segmental vitiligo, deepens Incyte’s...

Owens Corning (OC) is back in focus after announcing a reshaped leadership team, with Jonathan Collins set to become Chief Financial Officer and Executive Vice President, and Todd W. Fister promoted to President and Chief Operating Officer. See our latest analysis for Owens Corning. Owens Corning’s latest leadership changes land at a time when the stock is trading at US$138.90, with a 90 day share price return of 13.18% and a more muted 1 year total shareholder return of 4.30%. This suggests...

AbbVie stock slipped about 2.5% today and is roughly flat over the past month, even after a strong second quarter that pushed adjusted earnings per share to $3.65 and revenue to nearly $17.0b. The market is reacting to the near term. The numbers are pointing you to a longer story. The headline is simple. AbbVie just delivered double digit revenue growth in a period when investors are still focused on legacy patent risks and a very rich trailing P/E of about 123x. The real question now is how...

Advance Auto Parts stock is coming off a long weak stretch, with a sharply negative five year return, while the current valuation checks still suggest the shares are not a clear bargain. After a solid rebound this year, investors now face a stock that screens as expensive on broad metrics rather than obviously cheap after the pullback. Over the past five years, Advance Auto Parts has delivered a return of about 69.5% in decline, which puts extra focus on whether the recent recovery leaves...

Jabil stock has delivered a very large 5 year return, yet at around US$315 per share the intrinsic value estimate based on a Discounted Cash Flow (DCF) model and the market multiples both still point to the shares screening as undervalued. Jabil has returned 436.5% over the past 5 years, which puts extra focus on whether the current price still offers a margin between market value and intrinsic value. The key support for the current valuation is the market's view of Jabil's ability to keep...

The market loved nVent Electric’s latest quarter. The stock jumped 6.2% to US$153.83, even though it had been flat over the past week and slightly down over the past month and quarter. That is a sentiment reset in a single session. The spark was not a soft beat. nVent Electric delivered record Q2 sales of US$1.471b and adjusted earnings per share of US$1.45, with management lifting full year revenue and earnings guidance. Investors are treating this as confirmation that the data center and...

Surgery Partners (SGRY) recently reaffirmed its 2026 earnings guidance, telling investors to expect revenues between US$3.35b and US$3.45b. This keeps attention on how the company balances this outlook with ongoing operational challenges. See our latest analysis for Surgery Partners. Despite reaffirmed guidance, Surgery Partners’ recent trading tells a mixed story. The stock has fallen about 7% on a 30 day share price return basis but is still up nearly 8% over 90 days. The 1 year total...